Exploring Factors Affecting the Occurrence of Hypersensitivity Reactions Induced by Nonionic Iodine Contrast Media.

acute side effects hypersensitivity reactions independent factor multivariate analysis nonionic iodine contrast media

Journal

Journal of clinical pharmacology
ISSN: 1552-4604
Titre abrégé: J Clin Pharmacol
Pays: England
ID NLM: 0366372

Informations de publication

Date de publication:
09 2023
Historique:
received: 05 12 2022
accepted: 23 04 2023
medline: 14 8 2023
pubmed: 28 4 2023
entrez: 28 4 2023
Statut: ppublish

Résumé

Hypersensitivity reactions induced by nonionic iodine contrast media sometimes occur and can be life threatening. However, independent factors affecting their occurrence remain to be fully established. Therefore, the purpose of this study was to clarify independent factors affecting the occurrence of hypersensitivity reactions induced by nonionic iodine contrast media. Patients who received nonionic iodine contrast media at Keiyu Hospital from April 2014 to December 2019 were included. The adjusted odds ratio (OR) and 95% confidence interval (CI) for factors affecting hypersensitivity reactions induced by contrast media were calculated by logistic regression analysis. The multiple imputation method was used to impute missing data. Hypersensitivity reactions occurred in 0.72% (163 cases) of 22,695 cases enrolled in this study. In univariate analysis, 10 variables met the criteria of P < .05 and proportion of missing data <50%. In multivariate analysis, age (OR, 0.98; 95% CI, 0.97-0.99), outpatient status (OR, 2.08; 95% CI, 1.20-3.60), contrast medium iodine content (OR, 1.02; 95% CI, 1.01-1.04), history of drug allergy (OR, 2.41; 95% CI, 1.50-3.88), and asthma (OR, 17.4; 95% CI, 7.53-40.1) were identified as independent factors affecting contrast media-induced hypersensitivity reactions. Among these factors, history of drug allergy and asthma appear to be clinically relevant and reliable due to their high OR and plausible biological mechanisms, but the other three factors require further validation.

Identifiants

pubmed: 37114401
doi: 10.1002/jcph.2256
doi:

Substances chimiques

Iodine 9679TC07X4
Contrast Media 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1002-1008

Informations de copyright

© 2023 The Authors. The Journal of Clinical Pharmacology published by Wiley Periodicals LLC on behalf of American College of Clinical Pharmacology.

Références

Katayama H, Yamaguchi K, Kozuka T, Takashima T, Seez P, Matsuura K. Adverse reactions to ionic and nonionic contrast media. A report from the Japanese Committee on the Safety of Contrast Media. Radiology. 1990;175(3):621-628.
Schönmann C, Brockow K. Adverse reactions during procedures: hypersensitivity to contrast agents and dyes. Ann Allergy Asthma Immunol. 2020;124(2):156-164.
Namasivayam S, Kalra MK, Torres WE, Small WC. Adverse reactions to intravenous iodinated contrast media: a primer for radiologists. Emerg Radiol. 2006;12(5):210-215.
Rosado Ingelmo A, Doña Diaz I, Cabañas Moreno R, et al. Clinical Practice Guidelines for diagnosis and management of hypersensitivity reactions to contrast media. J Investig Allergol Clin Immunol. 2016;26(3):144-155
European Society of Urogenital Radiology. ESUR Guidelines on Contrast Media ver. 10.0. https://www.esur.org/wp-content/uploads/2022/03/ESUR-Guidelines-10_0-Final-Version.pdf2021. Accessed on November 11. 2022
American College of Radiology Committee on Drugs and Contrast Media. ACR Manual on Contrast Media 2020. https://xray.ufl.edu/wordpress/files/2020/05/2020_ACR_Manual_Contrast_Media.pdf. Accessed on November 11. 2022
Böhm I, Morelli J, Nairz K, Silva Hasembank Keller P, Heverhagen JT. Myths and misconceptions concerning contrast media-induced anaphylaxis: a narrative review. Postgrad Med. 2017;129(2):259-266.
Rawlins MD, Thompson JW. Mechanisms of adverse drug reactions. Davies's Textbook of Adverse Drug Reactions. Hodder Arnold;1991.
Lombardo P, Boehm I. Physiological reaction following contrast medium administration: What kind of reaction is this? Eur J Intern Med. 2019;62:e15.
Wu YW, Leow KS, Zhu Y, Tan CH. Prevention and management of adverse reactions induced by iodinated contrast media. Ann Acad Med Singap. 2016;45(4):157-164.
Kobayashi D, Takahashi O, Ueda T, Deshpande GA, Arioka H, Fukui T. Risk factors for adverse reactions from contrast agents for computed tomography. BMC Med Inform Decis Mak. 2013;13:18.
Lee SY, Kang DY, Kim JY, et al. Incidence and risk factors of immediate hypersensitivity reactions associated with low-osmolar iodinated contrast media: a longitudinal study based on a real-time monitoring system. J Investig Allergol Clin Immunol. 2019;29(6):444-450.
Cha MJ, Kang DY, Lee W, et al. Hypersensitivity reactions to iodinated contrast media: A multicenter study of 196 081 patients. Radiology. 2019;293(1):117-124.
Voltolini S, Cofini V, Murzilli F, et al. Hypersensitivity reactions to iodinate contrast media in Italy: a retrospective study. Characteristics of patients and risk factors. Eur Ann Allergy Clin Immunol. 2022; 54(2):60-67.
Li X, Liu H, Zhao L, et al. Clinical observation of adverse drug reactions to non-ionic iodinated contrast media in population with underlying diseases and risk factors. Br J Radiol. 2017;90(1070):20160729.
Park HJ, Son JH, Kim TB, et al. Relationship between lower dose and injection speed of iodinated contrast material for CT and acute hypersensitivity reactions: an observational study. Radiology. 2019; 293(3):565-572.
Matsuo S, Imai E, Horio M, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53(6):982-992.
Rubin DB. Multiple Imputation for Nonresponse in Surveys. New York: John Wiley & Sons Inc; 1987.
Raghavan R, Ashour FS, Bailey R. A review of cutoffs for nutritional biomarkers. Adv Nutr. 2016;7(1):112-120.
Abe S, Fukuda H, Tobe K, Ibukuro K. Protective effect against repeat adverse reactions to iodinated contrast medium: premedication vs. changing the contrast medium. Eur Radiol. 2016;26(7):2148-2154.
Lee SY, Yang MS, Choi YH, et al. Stratified premedication strategy for the prevention of contrast media hypersensitivity in high-risk patients. Ann Allergy Asthma Immunol. 2017;118(3):339-344.
Lee H, Song S, Oh YK, Kang W, Kim E. Is gender still a predisposing factor in contrast-media associated adverse drug reactions? A systematic review and meta-analysis of randomized trials and observational studies. Eur J Radiol. 2017;89:81-89.
Boehm I. Contrast medium and patients at risk: asthma. Acta Radiol. 2009;50(3):348.
Trcka J, Schmidt C, Seitz CS, Bröcker EB, Gross GE, Trautmann A. Anaphylaxis to iodinated contrast material: nonallergic hypersensitivity or IgE-mediated allergy? AJR Am J Roentgenol. 2008;190(3):666-670.
Tanno LK, Gonzalez-Estrada A, Olivieri B, Caminati M. Asthma and anaphylaxis. Asthma and anaphylaxis. Curr Opin Allergy Clin Immunol. 2019;19(5):447-455.
Torres MJ, Trautmann A, Böhm I, et al. Practice parameters for diagnosing and managing iodinated contrast media hypersensitivity. Allergy. 2021;76(5):1325-1339.

Auteurs

Ryouichi Chatani (R)

Keio University Faculty of Pharmacy, Minato-ku, Tokyo, Japan.

Sakura Kondo (S)

Keio University Faculty of Pharmacy, Minato-ku, Tokyo, Japan.

Tadamasa Kamimura (T)

Department of Pharmacy, Kanagawa Prefectural Keiyukai Keiyu Hospital, Yokohama, Kanagawa, Japan.

Shinya Suzuki (S)

Department of Pharmacy, Yokohama City Minato Red Cross Hospital, Yokohama, Kanagawa, Japan.

Eriko Komatsubara (E)

Department of Pharmacy, Kanagawa Prefectural Keiyukai Keiyu Hospital, Yokohama, Kanagawa, Japan.

Seiichi Hayashi (S)

Department of Pharmacy, Kanagawa Prefectural Keiyukai Keiyu Hospital, Yokohama, Kanagawa, Japan.

Masayuki Hashiguchi (M)

Keio University Faculty of Pharmacy, Minato-ku, Tokyo, Japan.

Hayato Kizaki (H)

Keio University Faculty of Pharmacy, Minato-ku, Tokyo, Japan.

Shungo Imai (S)

Keio University Faculty of Pharmacy, Minato-ku, Tokyo, Japan.

Satoko Hori (S)

Keio University Faculty of Pharmacy, Minato-ku, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH